Fmoc Amine PEG Amine, TFA Salt-·Ç·²¹ú¼Ê,Ö§Á´¾ÛÒÒ¶þ´¼ÑÜÉúÎï,Ö±Á´¾ÛÒÒ¶þ´¼ÑÜÉúÎï"> Fmoc Amine PEG Amine, TFA Salt ·Ç·²¹ú¼Ê¿Æ¼¼Ìṩ´óÅúÁ¿Éú²ú²úÆ·¼°GMP¼¶±ð²úÆ·£¬£¬£¬£¬£¬£¬ÈçÐ豨¼ÛÇëÓëÎÒÃÇÁªÏµ ¡£¡£¡£¡£¡£¡£¡£"> ·Ç·²¹ú¼Ê,Ö§Á´¾ÛÒÒ¶þ´¼ÑÜÉúÎï,Ö±Á´¾ÛÒÒ¶þ´¼ÑÜÉúÎï"> Fmoc Amine PEG Amine, TFA Salt-·Ç·²¹ú¼Ê,Ö§Á´¾ÛÒÒ¶þ´¼ÑÜÉúÎï,Ö±Á´¾ÛÒÒ¶þ´¼ÑÜÉúÎï"> Fmoc Amine PEG Amine, TFA Salt ·Ç·²¹ú¼Ê¿Æ¼¼Ìṩ´óÅúÁ¿Éú²ú²úÆ·¼°GMP¼¶±ð²úÆ·£¬£¬£¬£¬£¬£¬ÈçÐ豨¼ÛÇëÓëÎÒÃÇÁªÏµ ¡£¡£¡£¡£¡£¡£¡£">

·Ç·²¹ú¼Ê

²úÆ·ÖÐÐÄ

ÁªÏµ·Ç·²¹ú¼Ê

+86-010-82156767

ÏúÊÛרÓãº

+86-010-62983737 

+86-15522507305 

+86-15522507319 

+86-15522507326

µØÖ·£º±±¾©Êк£µíÇøÎ÷С¿Ú·66ºÅÖйش嶫Éý¿Æ¼¼Ô°C-1Â¥Èý²ã

undefined
+
  • undefined

Fmoc Amine PEG Amine, TFA Salt

²úÆ·´úºÅ£º

FMOC-PEG-NH2TFA

²úÆ·´¿¶È£º

¡Ý 95%

°ü×°¹æ¸ñ£º

1g, 10g, 100gµÈ£¨ÌØÊâ°ü×°ÐèÊÕÈ¡·Ö×°Óöȣ©

·Ö×ÓÁ¿£º

2000 Da,3500 Da, 5000 Da, 7500 DaµÈ

²úÆ·×Éѯ£º

¿ÆÑпͻ§Ð¡ÅúÁ¿Ò»¼ü²É¹ºµØÖ·£¨Ð¡ÓÚ5¿Ë£©

Á¬Ã¦Ïµ¥
  • ²úÆ·ÐÎò
  • ²Î¿¼ÎÄÏ×

  • ¡¡¡¡·Ç·²¹ú¼Ê¿Æ¼¼Éú²úµÄÒìÜ̼×ÑõôÊ°±»ù¾ÛÒÒ¶þ´¼°·Èý·úÒÒËáÑβúÆ·Öк¬Óа·»ùÍż°Êܱ£»£»£»£»£»£»¤µÄ°·»ù£¬£¬£¬£¬£¬£¬Í¨³£ÓÃ×÷Á½ÖÖ²î±ð»¯Ñ§ÎïÖʵĽ»Áª¼Á»ò¾àÀëÎï ¡£¡£¡£¡£¡£¡£¡£´ËÒ칦ЧPEGÑÜÉúÎïÖеÄPEG²¿·Ö¿ÉÌṩˮÈÜÐÔ¡¢ÉúÎïÏàÈÝÐÔ¼°ÈáÐÔ ¡£¡£¡£¡£¡£¡£¡£´Ë²úƷרÃÅÓ¦ÓÃÓÚ¿¹ÌåżÁªÒ©Îï(ADC¡¯s)µÄ¿ª·¢ ¡£¡£¡£¡£¡£¡£¡£

    ²úÆ·±àÂë

    ²úÆ·´úºÅ

    A5138

    FMOC-PEG2000-NH2TFA

    A5139

    FMOC-PEG3500-NH2TFA

    A5140

    FMOC-PEG5000-NH2TFA

    A5141

    FMOC-PEG7500-NH2TFA

    ¡¡¡¡·Ç·²¹ú¼Ê¿Æ¼¼ÌṩFMOC-PEG-NH2TFA·Ö×ÓÁ¿2000 Da,3500 Da, 5000 Da, 7500 DaµÄ²úÆ·1¿ËºÍ10¿Ë°ü×° ¡£¡£¡£¡£¡£¡£¡£

    ¡¡¡¡·Ç·²¹ú¼Ê¿Æ¼¼Ìṩ·Ö×°·þÎñ£¬£¬£¬£¬£¬£¬ÐèÒªÊÕÈ¡·Ö×°Óöȣ¬£¬£¬£¬£¬£¬ÈôÊÇÄúÐèÒª·ÖװΪÆäËû¹æ¸ñÇëÓëÎÒÃÇÁªÏµ ¡£¡£¡£¡£¡£¡£¡£

    ¡¡¡¡·Ç·²¹ú¼Ê¿Æ¼¼Í¬Ê±ÌṩÆäËû·Ö×ÓÁ¿µÄFMOC-PEG-NH2TFAÑÜÉúÎï²úÆ·£¬£¬£¬£¬£¬£¬ÈçÄãÐèÒªÇëÓëÎÒ˾sales@jenkem.comÁªÏµ ¡£¡£¡£¡£¡£¡£¡£

    ¡¡¡¡·Ç·²¹ú¼Ê¿Æ¼¼Ìṩ´óÅúÁ¿Éú²ú²úÆ·¼°GMP¼¶±ð²úÆ·£¬£¬£¬£¬£¬£¬ÈçÐ豨¼ÛÇëÓëÎÒÃÇÁªÏµ ¡£¡£¡£¡£¡£¡£¡£

     

  • ¡¡¡¡References:

    ¡¡¡¡1. Soni, K.S., et al., Tuning polypeptide-based micellar carrier for efficient combination therapy of ErbB2-positive breast cancer, Journal of Controlled Release, 2017, V. 264, P. 276-287.

    ¡¡¡¡2. Kim, H.C., et al., Folic Acid-Functionalized Polythiophene for Targeted Cellular Imaging, Journal of Nanoscience and Nanotechnology, 2016, 16:1, p. 189-195(7).

    ¡¡¡¡3. Fahrländer E., et al., PEGylated human serum albumin (HSA) nanoparticles: preparation, characterization and quantification of the PEGylation extent, Nanotechnology, 2015, 26(14):145103.

    ¡¡¡¡4. Desale, S.S., et al., Targeted delivery of platinum-taxane combination therapy in ovarian cancer, Journal of Controlled Release, 2015, 220B, P. 651-659.

²úƷѯ¼Û

ÍøÕ¾µØͼ